leadf
logo-loader

Medical technology & services

Add to MyProactive
Health

Oneview Healthcare with Proactive at the ASX Small and Mid Cap...

Paradigm Biopharmaceuticals Ltd - Investing in a biotech company? Here’s what you need to know Health Investing in a biotech company? Here’s what you need to know
2 weeks, 3 days ago
SUDA Pharmaceuticals Ltd - Health SUDA Pharmaceuticals appoints internationally recognised clinical...
3 weeks, 1 day ago
SUDA Pharmaceuticals Ltd - SUDA Pharmaceuticals advances insomnia, cancer treatment profiles in FY21 Health SUDA Pharmaceuticals advances insomnia, cancer treatment profiles...
3 weeks, 3 days ago
CardieX Ltd - Health CardieX anticipates 'historical' 5-year high revenue growth in...
3 weeks, 4 days ago
SUDA Pharmaceuticals Ltd - SUDA Pharmaceuticals appoints a cellular immunotherapies expert to its scientific advisory board
on 26/8/21
Bayer AG - CardieX expands chronic kidney disease clinical trial agreement with Bayer
on 25/8/21
SUDA Pharmaceuticals Ltd -
on 24/8/21
SUDA Pharmaceuticals Ltd - SUDA Pharmaceuticals remains focused on progressing ZolpiMist™ commercialisation
on 24/8/21
SUDA Pharmaceuticals Ltd - SUDA Pharmaceuticals sets sights on product development
on 19/8/21
SUDA Pharmaceuticals Ltd - SUDA Pharmaceuticals enters into collaborative research agreement with Imperial College London
on 16/8/21
SUDA Pharmaceuticals Ltd - SUDA Pharmaceuticals enhances board skillset with oncology experience
on 10/8/21
Atara Biotherapeutics - Suda Pharmaceuticals appoints senior cell and gene therapy manufacturing expert
on 2/8/21
Suda Pharmaceuticals ends June quarter with $6.7 million in bank as it prepares to move forward its iNKT cell therapy platform licence
on 26/7/21
CardieX Ltd - CardieX rounds off June quarter with strong sales, $3.67 million cash balance
on 26/7/21
SUDA Pharmaceuticals Ltd - Suda Pharmaceuticals' introduce novel iNKT cell therapy platform from Imperial College London
on 13/7/21
CardieX Ltd -
on 30/6/21
CardieX Ltd - CardieX’s SphygmoCor technology chosen for Yale University clinical trial
on 24/6/21
SUDA Pharmaceuticals Ltd - SUDA Pharmaceuticals shares jump 69.44% on heavily oversubscribed placement news raising $3.65 million
on 22/6/21
CardieX Ltd - CardieX subsidiary announces Strategic Collaboration Agreement with LifeQ for CONNEQT Wearable
on 22/6/21